These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 6244906)
1. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor. Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458 [TBL] [Abstract][Full Text] [Related]
3. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response. Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877 [TBL] [Abstract][Full Text] [Related]
4. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. Levine TB; Franciosa JA; Cohn JN Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102 [No Abstract] [Full Text] [Related]
5. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure. Packer M; Lee WH; Medina N; Yushak M J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397 [TBL] [Abstract][Full Text] [Related]
6. Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients. Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L Am J Cardiol; 1980 Aug; 46(2):295-300. PubMed ID: 6250392 [No Abstract] [Full Text] [Related]
7. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure. Packer M; Meller J; Medina N; Yushak M Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. Awan NA; Evenson MK; Needham KE; Win A; Mason DT Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100 [TBL] [Abstract][Full Text] [Related]
9. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure. Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders. Packer M; Medina N; Yushak M Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434 [TBL] [Abstract][Full Text] [Related]
11. Captopril in congestive heart failure: improved left ventricular function with decreased metabolic cost. Chatterjee K; Rouleau JL; Parmley WW Am Heart J; 1982 Nov; 104(5 Pt 2):1137-46. PubMed ID: 6291359 [TBL] [Abstract][Full Text] [Related]
12. Improvement of chronic congestive heart-failure by oral captopril. Turini GA; Brunner HR; Gribic M; Waeber B; Gavras H Lancet; 1979 Jun; 1(8128):1213-5. PubMed ID: 87679 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of captopril in patients with severe chronic heart failure. LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587 [TBL] [Abstract][Full Text] [Related]
14. Long-term control of congestive heart failure with captopril. Fouad FM; Tarazi RC; Bravo EL; Hart NJ; Castle LW; Salcedo EE Am J Cardiol; 1982 Apr; 49(6):1489-96. PubMed ID: 6803563 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure. Massie BM; Packer M; Hanlon JT; Combs DT J Am Coll Cardiol; 1983 Aug; 2(2):338-44. PubMed ID: 6345633 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise. Massie B; Kramer BL; Topic N; Henderson SG Circulation; 1982 Jun; 65(7):1374-81. PubMed ID: 6280890 [TBL] [Abstract][Full Text] [Related]
18. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. Packer M; Medina N; Yushak M; Meller J Circulation; 1983 Oct; 68(4):803-12. PubMed ID: 6352079 [TBL] [Abstract][Full Text] [Related]
19. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme]. Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239 [TBL] [Abstract][Full Text] [Related]
20. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure. Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]